UB-921 (trastuzumab biosimilar)
/ United BioPharma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
April 03, 2019
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of UB-921 in Healthy Volunteers
(clinicaltrials.gov)
- P1; N=18; Completed; Sponsor: United BioPharma; Active, not recruiting ➔ Completed; Trial completion date: Oct 2018 ➔ Apr 2019
Clinical • Trial completion • Trial completion date
1 to 1
Of
1
Go to page
1